Immune checkpoint blockade-based immunotherapy along with PDT could increase infiltration of tumor-specific effector T cells and decrease secretion of TGFβ, an immunosuppressive cytokine secreted by Tregs which have an autocrine role [66], might lead to lower tumor recurrence and higher patient survival rate. This evidence concerns the gene TGFB1 and neoplasm.